# PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)

> **NCT04142359** · — · TERMINATED · sponsor: **Altor BioScience** · enrollment: 1 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **BIOLOGICAL:** BCG in Combination with N-803
- **DRUG:** N-803 alone

## Key facts

- **NCT ID:** NCT04142359
- **Lead sponsor:** Altor BioScience
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-09
- **Primary completion:** 2020-04-06
- **Final completion:** 2020-04-06
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study was closed due to the recent pandemic and enrollment challenges.
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04142359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04142359, "PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04142359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*